Heart Rhythm Program, Southlake Regional Health Centre, Newmarket, ON, Canada L3Y 8C3.
Cardiol Res Pract. 2011 Mar 3;2011:589781. doi: 10.4061/2011/589781.
Atrial fibrillation (AF) is a common and frequently disabling chronic condition associated with significant patient morbidity and affecting an increasing stratum of our ageing society. Direct costs related to atrial fibrillation are comprised from direct cost of medical therapy, catheter ablation, and related hospitalizations and imaging procedures, with indirect costs related to complications of the primary therapeutic strategy, management of related conditions, as well as disability and loss in quality of life related to AF. Over the last decade, catheter ablation became a promising alternative to rate and rhythm control among symptomatic AF patients. The purpose of this paper is to describe the evidence on the financial implications related to ablation based on published data and authors' experience.
心房颤动（AF）是一种常见且经常致残的慢性疾病，与患者的高发病率相关，并影响着我们日益老龄化社会中的一个不断增长的阶层。与心房颤动相关的直接成本包括医疗治疗、导管消融以及相关住院和影像检查的直接成本，而间接成本则与主要治疗策略的并发症、相关疾病的管理以及与 AF 相关的残疾和生活质量下降有关。在过去的十年中，导管消融已成为有症状的 AF 患者控制心率和节律的一种有前途的替代方法。本文旨在根据已发表的数据和作者的经验，描述与消融相关的财务影响的证据。
